BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 24, 2009
View Archived Issues
Inhibitors of apoptosis inhibitor proteins (IAP) disclosed at Genentech for cancer
Read More
Thyroid-stimulating hormone receptor agonists created at NIH
Read More
N. lactamica outer membrane vesicle meningococcal vaccine tested in phase I study
Read More
Novel IKK2-inhibiting compounds tested for antiarthritic potential at GlaxoSmithKline
Read More
Pure androgen receptor antagonist CH-4933468 developed at Chugai
Read More
Inhibitors of CDK1, CDK5 and GSK-3 with anticancer activity developed at CNRS
Read More
Novel compounds for menopausal syndrome and oral contraception claimed by Bayer Schering Pharma
Read More
Wellstat Therapeutics claims compounds for treating type 2 diabetes
Read More
Lilly describes glucocorticoid receptor agonists for rheumatoid arthritis
Read More
Cannabinoid receptor ligands created for pain therapy at Purdue Pharma
Read More
Wyeth presents novel benzofuran analogues designed to inhibit NE reuptake
Read More
Cephalon details discovery and testing of c-Met inhibitors for cancer
Read More
Taspoglutide improves glycemic control in patients unresponsive to metformin
Read More
AstraZeneca Canada files NDS for FluMist vaccine
Read More
AMG-386 active and well tolerated in patients with advanced solid tumors
Read More
Health Canada approves Rituxan for treatment of CLL
Read More
Novel aromatase inhibitors claimed for cancer
Read More
The NIH awards grant to Advaxis for dual antigen vaccine
Read More
Yakult's Elplat approved for postoperative adjuvant chemotherapy of colon cancer
Read More
FDA approves two NDAs for Lundbeck's Sabril for IS and CPS
Read More
Biovail acquires U.S. and Canadian rights to develop and commercialize Santhera's fipamezole
Read More
Potential benefits for Avastin in second-line setting
Read More
Novartis' Xolair approved for severe persistent allergic asthma in children aged 6 to 11
Read More
FDA accepts for filing Cell Therapeutics' NDA for pixantrone in NHL
Read More
UCB and Novartis sign licensing agreement for cardiovascular, diabetes drugs
Read More